TSX:CURAPharmaceuticals
Does Curaleaf (TSX:CURA) Buyback Signal Strategic Discipline Or A Shift In Growth Priorities?
Earlier this month, Curaleaf Holdings, Inc. announced a Board-authorized share repurchase program on the TSX, allowing the company to cancel up to 34,388,831 shares, around 5% of its 687,776,631 outstanding common shares, by April 16, 2027.
This move to shrink the share count coincides with growing expectations of eased U.S. cannabis restrictions, together underscoring how capital allocation and regulation are reshaping Curaleaf’s outlook.
We’ll now explore how Curaleaf’s new buyback plan,...